R21 grant awarded with Dr. Abraham Palmer as a co-investigator
A new R21 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Marsida Kallupi, with Dr. Abraham Palmer as co-investigator.
The 2-year grant is titled “Enhancing Addiction Severity Prediction by Modulating GABAergic Activity in the Central Amygdala of RATTACA Rats” and it will start July 15, 2025 and end on June 30, 2027.
Congratulations!